Serial Number | 79325753 |
Word Mark | OMERO PLUS |
Filing Date | Tuesday, August 31, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, September 10, 2024 |
Registration Number | 7497634 |
Registration Date | Tuesday, September 10, 2024 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, November 29, 2022 |
Description of Mark | The mark consists of a hexagon shape formed of six oblong triangles where three of them are dark blue, one of them is light green, one is dark green and one is light blue; in the center of the shape is a dark blue circle; to the right of the hexagon shape is a dark blue plus symbol and the wording "OMERO PLUS" where the "O" is light green, the "M" is dark green, the "E" is light blue, the "RO" is dark blue and the "PLUS" is light blue. The color white represents background and/or transparent areas and is not claimed as a feature of the mark. |
Goods and Services | Downloadable computer software that is downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable computer software that is downloaded and installed from the Internet for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable data access and data management software tools that are downloaded and installed for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable electronic publications in the nature of scientific journals, periodicals and newsletters relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof. |
Indication of Colors claimed | The color(s) light green, dark green, light blue and dark blue is/are claimed as a feature of the mark. |
Goods and Services | Business services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science, namely, management of biological and biomedical data and images for business enterprises; data processing services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof. |
Goods and Services | Licensing of computer software for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof. |
Goods and Services | Design and development of computer software, data access and data management software tools for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; computer programming; installation, maintenance and repair of computer software; design of computer websites and maintenance thereof, all relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; software as a service (SaaS) featuring software for accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof. |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 6, 2021 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 6, 2021 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 6, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 6, 2021 |
Primary Code | 045 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Glencoe Software Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | US |
Party Name | Glencoe Software Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | US |
Party Name | Glencoe Software Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | US |
Event Date | Event Description |
Friday, June 10, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, November 18, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Thursday, December 2, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Monday, December 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, December 10, 2021 | APPLICATION FILING RECEIPT MAILED |
Monday, June 6, 2022 | ASSIGNED TO EXAMINER |
Thursday, June 9, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, June 28, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, July 19, 2022 | REFUSAL PROCESSED BY IB |
Monday, June 27, 2022 | REFUSAL PROCESSED BY MPU |
Wednesday, October 5, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, October 5, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, October 5, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, October 5, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, October 5, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, October 19, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, October 19, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, October 20, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 26, 2022 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, October 26, 2022 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 26, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, October 26, 2022 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, October 26, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 23, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, November 9, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 29, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, November 23, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Tuesday, November 29, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, November 30, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Wednesday, April 19, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, April 19, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Saturday, May 27, 2023 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
Monday, May 29, 2023 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
Thursday, June 1, 2023 | OPPOSITION INSTITUTED NO. 999999 |
Monday, December 12, 2022 | NOTIFICATION PROCESSED BY IB |
Tuesday, May 9, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, August 7, 2024 | OPPOSITION DISMISSED NO. 999999 |
Wednesday, August 7, 2024 | OPPOSITION TERMINATED NO. 999999 |
Wednesday, August 7, 2024 | TTAB RELEASE CASE TO TRADEMARKS |
Tuesday, September 10, 2024 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, September 10, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Monday, June 26, 2023 | REFUSAL PROCESSED BY IB |